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Biomimetic heterogenous elastic tissue development
Kai Jen Tsai1, Simon Dixon2, Luke Richard Hale1, Arnold Darbyshire1, Daniel Martin1,3 and Achala de Mel1
There is an unmet need for artiﬁcial tissue to address current limitations with donor organs and problems with donor site morbidity.
Despite the success with sophisticated tissue engineering endeavours, which employ cells as building blocks, they are limited to
dedicated labs suitable for cell culture, with associated high costs and long tissue maturation times before available for clinical use.
Direct 3D printing presents rapid, bespoke, acellular solutions for skull and bone repair or replacement, and can potentially address
the need for elastic tissue, which is a major constituent of smooth muscle, cartilage, ligaments and connective tissue that support
organs. Thermoplastic polyurethanes are one of the most versatile elastomeric polymers. Their segmented block copolymeric
nature, comprising of hard and soft segments allows for an almost limitless potential to control physical properties and mechanical
behaviour. Here we show direct 3D printing of biocompatible thermoplastic polyurethanes with Fused Deposition Modelling, with a
view to presenting cell independent in-situ tissue substitutes. This method can expeditiously and economically produce
heterogenous, biomimetic elastic tissue substitutes with controlled porosity to potentially facilitate vascularisation. The ﬂexibility of
this application is shown here with tubular constructs as exemplars. We demonstrate how these 3D printed constructs can be post-
processed to incorporate bioactive molecules. This efﬁcacious strategy, when combined with the privileges of digital healthcare,
can be used to produce bespoke elastic tissue substitutes in-situ, independent of extensive cell culture and may be developed as a
point-of-care therapy approach.
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INTRODUCTION
The long-standing desire to repair or replace, damaged or
diseased organs,1–6 was reﬂected in ancient mythology, biblical
stories and in ﬁction, before it evolved into a scientiﬁc and clinical
plausibility (Supplementary Figure 1). Tissue engineering meth-
odologies7–9 could be optimised for emergency surgeries and for
routine use in remote parts of the world that have no access to
specialised laboratories. Additive manufacturing, 3D printing and
associated multidisciplinary technologies present incredible
opportunities for developing bespoke prostheses, with ﬂexible
design capabilities and greater geometric accuracy for tissue
engineering.2 Fused deposition modelling (FDM) is one of the
most widely used 3D printing techniques. This methodology for
building 3D structure can facilitate material anisotropy, which is an
attractive feature when aiming for hetergenous tissue biomimicry.
A range of thermoplastic polymers including Thermoplastic
polyurethanes (TPU) have been demonstrated as being 3D
printable using FDM,10, 11 as well as the more commonly used
polycaprolactone (PCL) and polylactic acid (PLA.12, 13) although
PLA and PCL are inherently relatively stiff materials, and as a
consequence their application is limited—materials that offer
greater ﬂexibility, and tailorability to the application at hand such
as TPU are desired.
Commercally available FDM printers are relatively economical,
user friendly and do not require the specialised staff and safety
considerations associated with processes such as selective laser
sintering. The techniques demonstrated here are therefore widely
accessible and applicable even with limited resources.Printing
ﬂexible ﬁlaments by FDM is not without challenges, such as
directing ﬁlaments towards the extruder (Supplementary Figure 2),
requires manual adjustments to almost all currently available
FDMs. Only a small number of studies have explored direct
printing of ‘solvent free’ soft elastomers, which is a limitation
associated with ‘indirect printing’, where solvent based elastomers
are introduced to a 3D sacriﬁcial mould,14 which is an additional
step that is not required for direct 3D printing. With indirect
printing, the implementation of an internal pore structure might
limit the thickness and dimensions of the resulting 3D structure
due to the limited ability for solvent based elastomers to
homogenously penetrate through the patterned “mould”. In
addition, direct printing allows a combination of mechanical
properties from the use of multimaterials to generate a tailored
heterogeneous scaffold.
Despite the theoretical ability to produce a limitless range of
TPU elastomers, practical and commercial considerations dictate
that in reality only a small percentage of the potential material
grades are commercially available. In the case of medical device
applications the percentage is further limited by the use of
additives and processing aids in the polymer manufacturing,
which affect both biocompatibility and function. This is evidenced
by the very limited number of new medical grades of TPU
entering the market over the last decade. Here we have custom
synthesised a polyester (polycaprolactone) polyol based (TPU 80)
and a polyether polyol based (TPU 90) formulation (Supplemen-
tary Figure 3) in a ‘designed in’ rather than ‘engineered out’
approach to demonstrate the unique opportunities with TPU in
developing tissue substitutes. Both polymers were synthesised
using a precisely controlled step addition (prepolymer approach)
process using an aromatic diisocyanate and a short linear diol
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chain extender, which were subsequently extruded into 1.75 mm
ﬁlaments and then 3D printed. We used two different types of
commercially available FDM printers to evaluate the efﬁcacy of
fabrication of TPU ﬁlaments. The models used for 3D printing were
designed and sliced to incorporate micropatterns using open
source software, Blender™ and slic3r™, respectively.
RESULTS
Structural and mechanical biomimetic design ﬂexibility with direct
3D printed thermoplastic polyurethane
We have 3D printed tubular structures (Supplementary Figure 4)
and have evaluated the deﬁnition and the structural integrity of
prints. (Fig. 1a) The surface architecture of 3D tubular scaffolds,
printed with TPU90, demonstrated design ﬂexibility and deﬁnition,
with the surface area of a pore of a given pattern found to be
inversely proportional to the inﬁll density. (Fig. 1a and b) The
hexagonal style inﬁll produced a more compliant structure
compared to a linear inﬁll of the same density without
compromise to pore quality (Fig. 1b). We demonstrated the rapid
adaptability to mimic a range of elastic tubular structures (Fig. 1a
and b, Supplementary Figure 5) and we also demonstrated the
possibility to create pores distributed throughout all planes
(Supplementary Figure 4 E-I) which would be attractive for
vascular ingrowth. We demonstrated simple material anisotropy
dependant on inﬁll pattern with biaxial test TPU printed structures
(n = 5) (Supplementary Figure 6, Fig. 1c i, ii, iii). The scaffold is
signiﬁcantly (P < 0.05) more ﬂexible in x-axis and it is more rigid in
y-axis. It also demonstrated an inﬁll density-dependant increase in
elastic modulus. We also explored a commercially available TPU
(Porolay) which is available as a co-extrusion with Poly(vinyl
alcohol) (PVA). The PVA can be dissolved away in water conferring
porosity and ﬂexibility on the ﬁnal print. Here we demonstrate
biomimicry of a ligament structure with distinct collagen bundles
at the microscopic level (Fig. 1d i,ii).
Surface modiﬁcation for biofunctionalisation; post processing of
3D printed scaffolds
Surface functionalisation can modulate cell-material interactions,
including rapid cell adhesion and proliferation on a scaffold. We
demonstrate a post processing method, which enables surface
bio-functionalisation for enhanced cell-adhesion, whilst maintain-
ing bulk mechanical properties and structural integrity of 3D
printed constructs. To demonstrate this in-vitro, we have used a
solution-based TPU pre-polymer system which we have hybridised
with collagen, as an example of extracellular matrix (ECM)
component and L-Arginine methyl ester (L-AME) as a porogen15
(Fig. 2a, Supplementary Figure 7). We have tested the viability and
interactions of human dermal ﬁbroblasts (HDF) and bronchial
epithelial cells (BEC) (Fig. 2b). Quantiﬁcation with alamar blue
viablity tests (n = 8) has demonstrated that the L-AME and
collagen combined pre-polymer treated surface has the highest
cell viability (p < 0.05) at 24 and 72 h for HDF and BEC, respectively
(Supplementary Figure 8).
Structural, mechanical biomimicry of heterogenous tissue; trachea
as an exemplar
To demonstrate applications of our in-situ elastic tissue mimicry
approach and design ﬂexibility, we present evidence for structural
and mechanical biomimicry of an adult trachea. (Fig. 3a-i). Dual
printing of TPU has enabled complete, structural biomimicry of
this heterogenous tissue construct. The cartilage rings were
printed with biostable TPU 90 and trachealis muscle and
intermediate supporting tissue was printed with TPU 80 (Supple-
mentary Figure 9, Fig. 3a-ii, iii, iv). As a proof of principle, we have
post-processed the tracheal constructs to incorporate mesoporous
luminal surface whilst retaining bulk mechanical properties and
porosity (Fig. 3a-v) to support potential angiogenesis once
implanted in the body. This adult size construct (84 × 25 × 23
mm) of a complete tracheal construct was printed and processed
within 6 h. Such rapid efﬁciency is not possible with any other
technique presently available for tissue mimicry with current
processes requiring more typically a minimum of 24 h to
complete. Here we also show a computational attempt to adapt
a generic adult tracheal stent to be patient-speciﬁc with DICOM
data of a CT scan (Fig. 3b). This proposed approach of in-situ
printing can be coordinated remotely with centres to offer
bespoke, point of care therapy. The construct demonstrated good
handling when sutured with a 4.0 proline suture to a porcine
respiratory system (Supplementary Figure 10) and air tightness
when air ﬂow was introduced through an air bag with the trachea-
lung system placed under a saline bath. We demonstrate the
mechanical biomimicry16–21 and tissue anisotropy of the structure
(Fig. 3c) by excising distinct components (Supplementary Fig-
ure 11) to perform tensile tests that conﬁrmed tissue anisotropy
that is expected of tracheal tissue, with longitudinal elasticity
(3.25 MPa anterior and 2.85 MPa posterior segments) and radial
rigidity (10.42 MPa anterior, 7.08 MPa with posterior segments)
(Fig. 3c-i) In addition,we tested its ability to bend under
physiological conditions without luminal closure and regain its
form upon removal of force, which correlates well with the
compression tests with 12.86 MPa for lateral compression and
15.86 MPa for anterior compression (Fig. 3c ii, iii). We have
explored the degree of biomimicry of the tracheal construct under
a range of pressures with the trachea attached to a ventilator
system to determine potential response during coughing, crying
and forced expiration and inspiration with ultrasound measure-
ments22 (Supplementary Figure 12). The structure has sufﬁcient
strength to prevent luminal collapse but is not too rigid to
compromise optimal ventilation. The 3D printed construct
demonstrated an average of 15% change in diameter when
subjected to a pressure change from −100 to +80mmHg (Fig. 3c
iv, Supplementary Information). Furthermore the tests have shown
ultrasound to be informative in measuring compliance and this
technique can be adapted to investigate the functionality of a
range of 3D printed elastic structures. We demonstrated that by
simply changing the ratio of luminal diameter from 25/23 to 17/25
(Supplementary Figure 13) whilst maintaining all other parameters
constant, we can achieve signiﬁcantly different (p < 0.05) mechan-
ical strength for both lateral (14.86 MPa) and anterior compression,
(45.71 MPa). This suggests the potential for permutations that one
could test to ﬁne tune a structure of interest, including the
structural-mechanical nuances within the cartilage rings through
the introduction of design variations within the ring structure.
DISCUSSION
A tubular elastic structure with varying diameter and thickness is a
common structural feature of many organs23 and here we have
demonstrated the ﬂexibility and adaptability of direct 3D printing
of TPU to structurally and mechanically mimic these structures.
The ability to modulate inﬁll patterns with relatively simple
changes to computer assisted designs can inﬂuence the
compliance properties of the resulting 3D printed structures,
enabling mechanical biomimicry and controlled porosity that
could facilitate potential therapeutic angiogenesis. This channel to
ﬁne tune artiﬁcial elastic tissues by directly printing with TPU
offers excellent opportunities for a plethora of elastic tissue
replacements. The trachea is an outstanding candidate to
demonstrate structural heterogeneity, material anisotropy and
biomechanical versatility13, 18–21, 24–26 and we have successfully
demonstrated a structural and mechanical biomimicry of a full
structure of an adult trachea, particularly with distinct cartilage
rings and trachealis muscle as an exemplar biological structure.
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Fig. 1 Architectural and mechanical biomimetic design ﬂexibility with direct 3D printed thermoplastic polyurethane. a (i). 3D hollow tubular
CAD (20mm height × 15mm diameter) was sliced (Slic3r) to have a range of inﬁll densities in two different inﬁll patterns (hexagonal and
linear). Corresponding 3D printed structures were obtained with TPU90 with clear morphological deﬁnition. (n= 6) (ii). A range of 3D printed
tubular structures were obtained by varying the basic code (indicated in supplementary methods) for (the wall thickness, inﬁll density and
diameter) of the tubular hollow CAD structure for a (i). b (i). The ‘pore’ size is signiﬁcantly greater in the hexagonal constructs than linear. The
increase in inﬁll density decreased ‘pore’ size, but an exception observed between 60 to 80% in the hexagonal inﬁll (P> 0.05). (ii). Compression
strength of 3D printed structures corresponding to morphological details described in a (i). The hexagonal inﬁll was signiﬁcantly more
compliant than the linear inﬁll at 40, 60, 80% (P< 0.001) but not 20% (P> 0.05). Overall the linear inﬁll requires signiﬁcantly more force to
compress (P< 0.05). c (i) The surface architecture of 3D printed TPU90 scaffolds (15 × 15 × 1.5 mm) with signiﬁcantly different ﬁbre thickness in
opposite directions. (ii) Biaxial test demonstrating a density dependant increase in elastic modulus of scaffolds, as well as material anisotropy
with signiﬁcantly higher compressive stress in y-axis, and greater elongation in x-axis. (p< 0.05). (iii) The pore size of the scaffolds is inversely
related to the inﬁll density (p< 0.05). d (i) a SEM of a 3D printed TPU90 as a ligament structure that mimics collagen ﬁbre morphology b with
an inﬁll gradient (indicated with double headed arrows) to modulate varying tissue interphases. (ii) SEM of Porolay (PVA + TPU) biomimicking
ﬁbrous morphology as potential substitutes for connective tissue
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Previous studies have shown encouraging results with TPU as a
relatively small “patch” in-vivo.11 Although there was still a need to
produce a scaffold, which can essentially self-support in form and
function, which we have addressed here, with dual printing of TPU
for the ﬁrst time without a solvent based TPU printing system, that
mimics to a great extend the biomechanics and macro structure of
an adult trachea, (Fig. 3) thus supporting our aim to develop a
path with 3D printing TPU for wider clinical applications. A solvent
free, biogedradable, water based TPU has also been tested10 as a
scaffold, but is not self supporting, and required to be printed with
a bespoke, highly complex system which would be less practical
as a potential point-of-care system. Porolay, with its combination
of PVA and TPU as demonstrated here in this study, offers yet
another interesting co-extrusion polymer system with a mode of
controlling structural properties of TPU based 3D structures.
Cell-material interactions can be inﬂuenced by the presence of
bioactive molecules such as those that mimic ECM for cell
adhesion, antibacterial molecules to prevent implant associated
infection, and antithrombogenic molecules to confer haemocom-
patibility and mimic the endothelium.15, 27–29 This surface
Fig. 2 Surface modiﬁcation for biofunctionalisation; post processing of 3D printed scaffolds. a Diagrammatic illustration of post processing of 3D
printed scaffold, with collagen as an example of ECM component, L-AME as example bioactive molecule, which were introduced with solution
based pre-polymer acting as a ‘glue’. Subpanels i-iv indicate the order in which post-processing of scaffolds can be carried out to obtain a
biofunctionalised 3D printed scaffold. b Cell interactions on 3D printed scaffold surface (i) DAPI Fluorescence staining (Blue) demonstrating
presence of cells on the scaffold (stained in red). SEM images. (ii) a, b. (higher mag). HDF at day 3 on 3D printed TPU90 surface. c, d. (higher mag)
HDF at day 3 seeded on 3D printed TPU90 surface functionalised with L-AME. Red arrow indicating L-AME pores on the scaffold. e, f. (higher mag)
HDFs at day 3 seeded on 3D printed TPU90 surface functionalised with collagen. (iii) BEC (at day 14) seeded as a submerged culture on 3D printed
TPU80 surface biofunctionalised with collagen and L-AME. a. Mucus synthesis indicated within red circle. b. a cell prominent with Microvilli
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modiﬁcation method demonstrated here can serve as an effective
platform technology for the integration of a plethora of
biomolecules for cell-material interactions. It is also an effective
‘seal’ at the luminal phase to modulate permeability. The solution
based pre-polymer system, which acts as a ‘glue’ is an alternative
to genipin, muscle adhesive proteins, which may be used as a
cross linker for surface functionalisation and molecular biomimi-
cry. 3D printed TPU elastic structure mimics should be ideally
introduced in-vivo with autologous platelet rich plasma (PRP) gel
as routine practice to accelerate blood vessel formation. PRP gel
consists of growth factors that promote angiogenesis, as well as
stem cell migration to induce wound healing30–32 Therefore PRP
gel may work in synergy with optimally-interconnected porous
networks which 3D printing can create to facilitate vascularisation
of structures. It is of interest for future studies to explore 3D
printing of TPU to produce celia mimics and potentially replace a
role for celiated epithelium within the lumen as demonstrated
previously with 3D printed microﬁbers for other applications.33
3D printed biomimetic tissue
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The method of TPU fabrication and biofunctionalisation
presented here may be of interest for the rapid generation of
experimental models to explore mechanosensitivity of cells.34, 35
There is also further potential to optimise FDM printers for highly
ﬂexible TPUs to eliminate the need for routine manual adjust-
ments during processing, potentially through advanced FDM
printers, which can directly introduce polymer pellets free from
solvent thus bypassing any limitations associated with ﬁlaments.
The innovative platform technology which we present in this
study is elegantly simple, using minimum materials, which can be
maintained as stock extrusions that can be processed on standard,
accessible printing equipment without the requirement for
extensive preparation or post process clean up. Regulatory
qualiﬁcation of tissue implants are both device and location
speciﬁc, following closely controlled national and internationally
recognised guidelines and standards. By reducing the number of
material components and process steps this ﬂexible, core process
can lend itself to multiple device applications and constructs,
which are easily sterilisable within an operating theatre setting
and would enable this to potentially progress to become routine
practice in the clinical setting at the point of care.
METHODS AND MATERIALS
Materials for biomimetic scaffolds and characterisation
Thermoplastic polyurethanes, with the compositional data indicated in the
Table 1, were synthesised using a proprietary two stage process involving
the preparation of a controlled prepolymer of polyol with diisocyanate and
a subsequent chain extension step with a short chain diol to form a highly
linear, narrow molecular weight distribution TPU polymer.
Filament formation. 1.75 mm ﬁlaments were extruded for each of the
above TPU’s using a standard plastic extrusion set up as illustrated in
Supplementary Figure 14
The polymers were dried at 80 °C for a minimum of 4 h prior to
extrusion.
We also used commercially available Porolay, LAY-FOMM40 and LAY-
FOMM60, ﬁlaments to demonstrate the versatility of TPU that could
potentially be utilised to mimic elastic tissues.
CAD and 3D printing
Open source 3D modelling programme Blender™ (Stichting Blender
Foundation, Amsterdam, Netherlands) was used to model 3D objects to
obtain STL ﬁle formats, which were then sliced in open source Slic3r™
software to obtain G-codes to be printed with Sharbot Next generation
desktop 3D printer (Sharebot S.r.L, nibionno (lc) Italy) or Makerbot slicing
software (MakerBot® Industries, LLC, USA) to convert STL into.×3 g for
printing using 3dison Mulit 3D printer (Rokit, Korea). Both printers have dual
extrusion capability, and this feature was utilised to print tracheal constructs
with both TPU 90 and TPU80 for the respective tissue components.
Filaments were extruded at a temperature of 236 °C at a rate of 2 mm/s.
We also used a 3D image processing and mesh generating software,
Simpleware™ (ScanIP and + CAD) to obtain and generate pores within 3D
scaffolds, as well as density gradients for potentially mimicking distinct
tissue interphases. (Figure Supplementay Information)
We also used ScanIP and + CAD to explore the potential to ﬁt a generic
adult tracheal stent to be a bespoke structure. (Fig. 2b ii)
Biomechanical testing
A series of biomechanical tests were performed on test samples (n = 8)
using Instron 5565 with ‘Bluehill’ software and material testing frame with
a 500 N capacitor. The sample type and test settings for the respective
tests are shown in the following Table 2.
Biaxial test
TPU90 was 3D printed obtain 15 × 15 × 1mm square scaffolds with
rectilinear inﬁll 20, 40, 60, and 80% densities. Samples were immersed in
a water bath, which was maintained at 37 °C. Each sample was pre-
conditioned at 100mN with 8 cycles within 10 s, followed by 100% of
displacement dependant tests within 40 s (BioTester Biaxial test system,
CellScale, USA).
Compliance testing of tracheal constructs
Each end of the tracheal tests samples were sealed with an intubation tube
with an endotracheal cuff inﬂator. Attached to one tube is a pressure
monitor measuring mmHg (Comark, Fluke, UK) and to the other a 50ml
syringe. This system can then manually change the pressure within the 3D
printed tracheal construct from −200 to +100mmhg. The centre of the
trachea was placed with an VFX 9–4 ultrasound probe (Sonoline Antares,
Siemens Medical Solutions Inc, USA) set to a frequency range of 3.8 Mhz
with tissue harmonics (THI) engaged and a dynamic range of 55db.
(Supplementary Figure 4). This generated the optimal image of the trachea
both longitudinally and radially. The diameter of the trachea was then
Fig. 3 Structural, mechanical biomimicry of heterogenous tissue; trachea as an exemplar. a Structural biomimicry of an adult trachea: (i)
Trachea is relatively static, longitudinally ﬂexible but radially rigid with intermittent cartilage ‘c’ shaped rings, which maintains luminal
structure, with a softer trachealis muscle in the posterior providing the compliance for optimal ventilation.13, 18, 19, 24–26 (ii) 3D CAD model of
trachea generated using Blender™ software. (iii) STL of the CAD (ii) was sliced in slic3r™ (SI) and 3D printed with a dual extrusion FDM printer
with TPU 90 to mimic cartilaginous rings and TPU 80 for softer trachaelis muscle and connective tissue. (iv) 3D printed TPU biomimetic
tracheal structure. (v) Ultrastructure of the 3D printed biomimetic tracheal construct; SEM images of respective cross sectional and surface
images. a luminal surface post processed with L-AME and collagen b cross sectional view illustrating the structure to potentially facilitate
blood vessel inﬁltration. b (i) SimplewareTM software modelling of generic CAD of a trachea to match a patient trachea (CT scan) as a potential
stent. c Mechanical and functional biomimicry. (i) Tracheal segements (n= 12) demonstrated greater strength radially (p< 0.01) and greater
longitudinal elongation (p< 0.05) resulting in signiﬁcantly lower, elastic modulus (p< 0.05) for longitudinal segments (n= 12) compared to
circumferential segments (n= 10) with no signiﬁcant difference of elastic modulus between anterior and posterior longitudinal segments (p>
0.05) but signiﬁcantly higher elastic modulus for anterior circumferential segments compared to that of posterial circumferential segments. (ii)
Greater force (p= 0.05) was required to compress tracheal segments (25/23) (n= 8) with anterior compression than required to compress
laterally. (iii) Flexibility in bending; the constructs were bent in the anterior plane with ease without causing luminal closure and returned to
their original shape upon removal of the force. Constructs (n= 5) were laterally bent with even greater ease (p= 0.05). (iv) Compliance under a
range of pressures monitored with ultrasoundscans, with the probe placed a across and b along the 3D printed tracheal construct. Double
headed arrows on scans indicate maximum distension at a given pressure
Table 1. Compositional data of thermoplastic polyurethanes
Polymer code TPU 90
Description Linear aromatic polyether
urethane
Raw materials % Supplier
Polyether polyol (2000mwt) 63.01 IMCD
4,4 -Methylenebis(phenyl isocyanate), 29.64 Borsodchem
1,4 Butane diol 7.35 Whyte chemicals
TPU 80
Polycaprolactone diol (2000mwt) 68.76 Perstorp
4,4-Methylenebis(phenyl isocyanate), 25.72 Borsodchem
1,4 Butane diol 5.52 Whyte chemicals
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traced within a range of induced pressures. An Oxylog 3000 ventilator
(Dräger, UK) was also used to provide the pressure instead of a syringe on
a number of tests. Testing a range of pressures from 15 to 60mBar at a
frequency of 20 breaths/minute. An inﬂatable balloon was attached to the
opposite end in place of the pressure monitor. This contained the high
volume of air generated by the ventilator in order for it to function.
Surface functionalisation
a. Solution-based TPU pre-polymer system Poly(hexamethylenecarbo-
nate) diol, 2000mwt, (UBE, industries Ltd) was placed in a 250ml
reaction ﬂask equipped with mechanical stirrer and nitrogen inlet.
Flake 4,4′-Methylenebis(phenyl isocyanate), MDI, (Sigma Aldrich), was
added to the polyol and then reacted, under nitrogen, at 75–85 °C for
90min to form a pre-polymer with an NCO content of 4%. Dry
Tetrahydrofuran (Sigma Aldrich) was added slowly to form a 20%
solution of pre-polymer by weight.
b. Biofuctionalisation Exemplar bioactive molecules, collagen (BioHorein,
Thaiwan) and L-arginine methyl ester dihydrochloride (L-AME) (Sigma
Aldrich) were dispersed within the pre-polymer and then the 3D
printed scaffold surfaces were immersed and maintained in contact for
~10min (as determined to be optimal for surface modiﬁcation). After
removing from the solution, the solvent was allowed to evaporate at
(65 °C) to obtain a modiﬁed, bioactive surface (Supplementary Figure 7)
whilst retaining the bulk properties of the 3D printed scaffolds. (Fig. 3a)
Material characterisation
Post processed materials were characterised by:
1. Contact angle measurements (Krüss DSA100)-to observe degree of
surface wettability
2. FTIR measurements-Jasco FT/IR-4200 spectrometer, Spectra Manager
II software.
3. SEM—(Ziess, EVO HD15) to analyse scaffold topography
Cell culture
Standard cell culture conditions were carried out for both HDF (Life
technologies, C-013-5C) and BEC (Caltag Medsystem, SC-3211, SC-3210) as
per manufacturer’s advice. 3D printed test scaffolds, which were prepared
and transferred to ﬁt within 24-well cell culture plates were immersed in
70% ethanol and rinsed with sterilse PBS before placing the plates with the
3D printed scaffolds under UV radiation overnight in a cell culture hood.
The test scaffolds were introduced with respective cell culture media (as
noted above) for 3 h at 37 °C to equilibriate and then cells introduced at a
cell density of 10,000 cells/well of HDF and at a cell density of 50,000 cells/
well of BEC, which were expanded and cultured following supplier
instructions under physiological conditions. Cell viability was determined
with Alamar blue reagent at 10% (ThermoFisher, DAL1025). Cells adhered
on scaffolds were stained with standard protocols with DAPI ThermoFisher,
D371 and the scaffold was stained with rhodamine before images were
obtained using Zeiss Axio Observer Z1.
Material cell morphology, microscopy and SEM
Macro-morphology and pore size estimation. Photographic images of each
sample were obtained at 100× magniﬁcation with a celestron handheld
digital microscope (Celestron, USA) and ImageJ image processing software
(National Institute of Health, USA) was used to determine the average size
of pores on the respective material surfaces. For scanning electron
microscopy, samples were sputter-coated with 5 nm of gold-nanoparticles
using a plasma sputter-coater (Quorum Q15ORS) and samples were
imaged using JEOL JSM-7401F ﬁeld emission scanning electron micro-
scope or Zeiss EVO HD15 microscope.
Test samples for SEM with cells were ﬁxed (in 300 μL 0.1 M Sodium
Cacodylate buffer with 2% PFA and 1.5% GTA) and critical point dried
before being processed for analysis.
Statistical analysis
P < 0.05 was considered statically signiﬁcant, and the null hypothesis that
the data is normally distributed is rejected. Ordinary ANOVA test was
conducted for normally distributed data with Bonferroni post hoc test.
Kruskal–Walli test was conducted for data that is not normally distributed
with Dunn’s post hoc test. Tests samples were kept as n = 6 unless
otherwise stated.
Data availability
All relevant data are available from the authors
ACKNOWLEDGEMENTS
Authors would like to thank Dr Mouhalan Kanapathy for expert assistance with suturing
tracheal constructs to porcine respiratory system to test mechanical and structural
patency. We would like to thank Dr Githa Madani for providing with the DICOM ﬁles for
modelling, as well as Dr Ryo Torri at UCL, and Dr Celia Butler at Simpleware and for their
extensive, generous support throughout the study with aspects of 3D modelling, Dr
Matt Barlett for assistance with ultrasound measurements and Ms Helen McKenna at the
Royal Free Hospital for tremendous support with the ventilator set-up. Components of
this work was carried out by Halimat Afolabi (MBBS student) as part of a summer
research programme and N Brown, N Wadlie (year 3 Medical students at UCL) as part of
their intercalated BSc project under the supervision of Achala de Mel (course director of
iBSc Surgical Sciences). AdM is an Investigator of direct 3D printing project, which was
partly funded by EPSRC Additive Manufacturing in Healthcare grant project EP/L020904/
1 and KJT is partically funded by BioHORIEN Biochemical Technology Co-Ltd. Authors
would like to gratefully acknolwdge Biomer Technology Ltd for their in-kind support of
material and material development expertise for this project.
AUTHOR CONTRIBUTIONS
K.J.T. performed experiments, prepared diagrams/ﬁgures and wrote components of the
manuscript. S.D. synthesised thermoplastic material, adviced on material processing and
wrote components of the manuscript. L.H. performed experiments, prepared diagrams/
ﬁgures and wrote components of the manuscript. A.D. manufactured materials for
biofucntionalisation and guided on biomechanical tests. D.M. guided on compliance
testing and clinical relevance. A.d.M. conceived, and designed the study and wrote the
main manuscript. All authors have reviewed the manuscript.
ADDITIONAL INFORMATION
Supplementary Information accompanies the paper on the npj Regenerative Medicine
website (doi:10.1038/s41536-017-0021-4).
Competing interests: The authors declare that they have no competing ﬁnancial
interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional
claims in published maps and institutional afﬁliations.
Table 2. Details of sample types and test settings of respective biomechnical evaluations
Test Tensile Compression 3 point bend
Sample type Dumbell section (50mm length)
excised as indicated (Supplementary
Figure 10)
Samples of approx 15mm in height Adult trachea samples 84 × 25 × 23mm
Test Conditions Cross head speed −20mm/min
Guage length-20mm
Crosshead speed 10mm/min Crosshead speed-10mm/min
Test description
summary
Tensile tests were carried out
essentially in accordance with
ISO37:2011
Samples were compressed to 50% of their
original width. Each sample was pre-
conditioned (at a rate of 15mm/s)
Trachea samples were subjected to three
point bend test and the force required to
move at a speed of 10mm/min was
recorded
3D printed biomimetic tissue
KJ Tsai et al.
7
Published in partnership with the Australian Regenerative Medicine Institute npj Regenerative Medicine (2017)  16 
REFERENCES
1. Marx, V. Tissue engineering: Organs from the lab. Nature 522, 373–377 (2015).
2. de Mel, A. Three-dimensional printing and the surgeon. Br. J. Surg. 103, 786–788
(2016).
3. Kang, H. W. et al. A 3D bioprinting system to produce human-scale tissue con-
structs with structural integrity. Nat. Biotechnol. 34, 312–319 (2016).
4. Murphy, S. V. & Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32,
773–785 (2014).
5. Park, E. K. et al. Cranioplasty enhanced by three-dimensional printing: custom-
made three-dimensional-printed titanium implants for skull defects. J. Craniofac.
Surg. 27, 943–949 (2016).
6. Steinbacher, D. M. Three-dimensional analysis and surgical planning in cranio-
maxillofacial surgery. J. Oral. Maxillofac. Surg. 73, S40–S56 (2015).
7. Pashuck, E. T. & Stevens, M. M. Designing regenerative biomaterial therapies for
the clinic. Sci. Transl. Med. 4, 160sr4 (2012).
8. Skardal, A. & Atala, A. Biomaterials for integration with 3-D bioprinting. Ann.
Biomed. Eng. 43, 730–746 (2015).
9. Xu, T. et al. Complex heterogeneous tissue constructs containing multiple cell
types prepared by inkjet printing technology. Biomaterials 34, 130–139 (2013).
10. Hung, K. C., Tseng, C. S., Dai, L. G. & Hsu, S. H. Water-based polyurethane 3D
printed scaffolds with controlled release function for customized cartilage tissue
engineering. Biomaterials 83, 156–168 (2016).
11. Jung, S. Y. et al. 3D printed polyurethane prosthesis for partial tracheal recon-
struction: a pilot animal study. Biofabrication 8, 045015 (2016).
12. Korpela, J. et al. Biodegradable and bioactive porous scaffold structures prepared
using fused deposition modeling. J. Biomed. Mater. Res. B. Appl. Biomater. 101,
610–619 (2013).
13. Makitie, A. A. et al. Novel additive manufactured scaffolds for tissue engineered
trachea research. Acta. Otolaryngol. 133, 412–417 (2013).
14. Mohanty, S. et al. Fabrication of scalable and structured tissue engineering
scaffolds using water dissolvable sacriﬁcial 3D printed moulds. Mater. Sci. Eng C.
Mater. Biol. Appl. 55, 569–578 (2015).
15. Everett, W. et al. A material conferring hemocompatibility. Sci. Rep. 6, 26848
(2016).
16. Boiselle, P. M. et al. Tracheal collapsibility in healthy volunteers during forced
expiration: assessment with multidetector CT. Radiology 252, 255–262 (2009).
17. Melissinos, C. G. & Mead, J. Maximum expiratory ﬂow changes induced by
longitudinal tension on trachea in normal subjects. J. Appl. Physiol. 43, 537–544
(1977).
18. Rains, J. K., Bert, J. L., Roberts, C. R. & Pare, P. D. Mechanical properties of human
tracheal cartilage. J. Appl. Physiol. (1985) 72, 219–225 (1992).
19. Roberts, C. R. et al. Ultrastructure and tensile properties of human tracheal car-
tilage. J. Biomech. 31, 81–86 (1998).
20. Teng, Z., Ochoa, I., Li, Z. & Doblare, M. Study of tracheal collapsibility, compliance
and stress by considering its asymmetric geometry. Med. Eng. Phys. 31, 328–336
(2009).
21. Teng, Z. et al. Anisotropic material behaviours of soft tissues in human trachea: an
experimental study. J. Biomech. 45, 1717–1723 (2012).
22. Diwakar, A. et al. Sonographic evidence of abnormal tracheal cartilage ring
structure in cystic ﬁbrosis. Laryngoscope 125, 2398–2404 (2015).
23. Saksena, R., Gao, C., Wilcox, M., & de Mel, A. Tubular organ epithelialisation. J.
Tissue. Eng. 7, 1–16 (2016).
24. Mansﬁeld, E. G., Greene, V. K. Jr. & Auguste, D. T. Patterned, tubular scaffolds
mimic longitudinal and radial mechanics of the neonatal trachea. Acta. Biomater.
33, 176–182 (2016).
25. Hoffman, B., Martin, M., Brown, B. N., Bonassar, L. J., & Cheetham, J. Biomechanical
and biochemical characterization of porcine tracheal cartilage. Laryngoscope 126,
E325–E331 (2016).
26. Delaere, P. & Van, R. D. Tracheal replacement. J. Thorac. Dis 8, S186–S196 (2016).
27. Pati, F. et al. Ornamenting 3D printed scaffolds with cell-laid extracellular matrix
for bone tissue regeneration. Biomaterials 37, 230–241 (2015).
28. Nuhiji, E. et al. Biofunctionalization of 3D nylon 6,6 scaffolds using a two-step
surface modiﬁcation. ACS Appl. Mater. Interfaces. 4, 2912–2919 (2012).
29. Pati, F. et al. Printing three-dimensional tissue analogues with decellularized
extracellular matrix bioink. Nat. Commun. 5, 3935 (2014).
30. Wang, B. et al. Platelet-rich plasma reduces skin ﬂap inﬂammatory cells inﬁltration
and improves survival rates through induction of angiogenesis: An experiment in
rabbits. J. Plast. Surg. Hand Surg. 50, 239–245 (2016).
31. Mammoto, T. et al. Acceleration of lung regeneration by platelet-rich plasma
extract through the low-density lipoprotein receptor-related protein 5-Tie2
pathway. Am. J. Respir. Cell. Mol. Biol. 54, 103–113 (2016).
32. Fernandez-Moure, J. S. et al. Platelet rich plasma enhances tissue incorporation of
biologic mesh. J. Surg. Res. 199, 412–419 (2015).
33. Ou, J. et al. Cilllia-3D Printed Micro-Pillar Structures for Surface Texture, Actuation
and Sensing. doi:10.1145/2858036.2858257. 16 A.D.
34. Mason, B., Califano, J. P., & Reinhart-King, C. Matrix stiffness: a regulator of cellular
behavior and tissue formation. Eng. Biomater. Regen. Med. 19–37 (2012).
35. Kollmannsberger, P., Bidan, C. M., Dunlop, J. W. C. & Fratzl, P. The physics of tissue
patterning and extracellular matrix organisation: how cells join forces. Soft Matter
7, 9549–9560 (2011).
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in anymedium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visithttp://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2017
3D printed biomimetic tissue
KJ Tsai et al.
8
npj Regenerative Medicine (2017)  16 Published in partnership with the Australian Regenerative Medicine Institute
